Structural Basis of Targeted Imaging and Therapy in Cancer Explorations with the Epigenetic Drugs

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Cancer arises from aberrant epigenetic regulation of gene expression.
• Epigenetics involves modifications to DNA or histones, altering phenotypes without changing the genome.
• Reprogramming the cancer epigenome is crucial for effective cancer treatment and overcoming drug resistance.

Purpose of the Study:

• To highlight epigenetic pathways implicated in cancer.
• To discuss potential small molecule inhibitors and epidrugs targeting epigenetic modifications.
• To explore novel therapeutic strategies including nanomaterials and imaging for enhanced cancer treatment.

Main Methods:

• Review of current literature on epigenetic pathways in cancer.
• Analysis of small molecule inhibitors targeting DNA methyltransferase and histone modification.
• Discussion of emerging therapies utilizing nanomaterials and advanced imaging techniques.

Main Results:

• Epigenetic drug development shows promise for cancer therapy.
• Targeting cancer epigenetics faces challenges due to a lack of selective and effective small molecules.
• Structural insights into novel drug discovery for epigenetic targets are crucial.

Conclusions:

• Epigenetic reprogramming is a vital strategy in cancer therapy.
• Development of targeted epidrugs, including small molecules, nanomaterials, and imaging agents, is essential.
• Further research into structural aspects of novel epigenetic drugs will improve cancer treatment efficacy.